lancet-header
Preprints with The Lancet is part of SSRNĀ“s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The LancetĀ“s FAQ page, and for any feedback please contact preprints@lancet.com

FoxO1-Mediated Inhibition of STAT1 Alleviates Tubulointerstitial Fibrosis and Tubule Apoptosis in Diabetic Kidney Disease

46 Pages Posted: 2 Aug 2019

See all articles by Guijun Qin

Guijun Qin

Zhengzhou University - Division of Endocrinology

Fengjuan Huang

Zhengzhou University - Division of Endocrinology

Qingzhu Wang

Zhengzhou University - Division of Endocrinology

Feng Guo

Zhengzhou University - Department of Endocrinology

Yanyan Zhao

Zhengzhou University - Department of Endocrinology

Linlin Ji

Zhengzhou University - First Affiliated Hospital

Tingting An

Zhengzhou University - First Affiliated Hospital

Yi Song

Zhengzhou University - First Affiliated Hospital

Yang Liu

Zhengzhou University - First Affiliated Hospital

Yanyan He

Zhengzhou University - First Affiliated Hospital

More...

Abstract

Background: Tubulointerstitial fibrosis (TIF) plays an important role in the progression of diabetic kidney disease (DKD). Forkhead box O1 (FoxO1) is involved in the regulation of metabolism and cell apoptosis, but its function in renal TIF induced by DKD is less well understood.

Methods: Both in vitro and in vivo assays were performed to investigate the roles of FoxO1 in TIF induced by diabetes. A mouse model with kidney-specific overexpression of Pax2-3aFoxO1 was used to investigate the functions of FoxO1 in vivo. The in vitro functions of FoxO1 were analyzed in HK-2 cells with 3aFoxO1-knockin (3aFoxO1-KI) or FoxO1-knockdown (FoxO1-KD) via CRISPR/Cas9. Western blot, immunohistochemistry and chromatin immunoprecipitation were used to explore the underlying mechanisms.

Findings: In vivo study showed that kidney-specific overexpression of Pax2-3aFoxO1 significantly reduced the expression of STAT1 with resultant renal functional impairment, retarding renal TIF and apoptosis in diabetic mice. Meanwhile, We observed that FoxO1-KD in HK-2 cells aggravated the expression of STAT1, leading to activation of epithelial-to-mesenchymal transition (EMT) and intrinsic apoptotic pathway. Conversely, EMT and apoptosis were significantly attenuated in HK-2 cells with 3aFoxO1-KI under hyperglycemic conditions.

Interpretation: Taken together, these data suggest that the protection role of FoxO1 against renal TIF and apoptosis in DKD is likely in part to target STAT1 signaling, which may be a promising strategy for long-term treatment of DKD.

Funding Statement: This work was supported by grants from the National Natural Science Foundation of China (grant numbers: 81570746 and 81770812).

Declaration of Interests: The authors declare no competing financial interests.

Ethics Approval Statement: The Ethics Committee from Zhengzhou University approved the use of patient tissue samples in this study. All procedures conducted in accordance with the Principles of Laboratory Animal Care, and were approved by the institutional committees of the Animal Research Committee and Animal Ethics Committee of Zhengzhou University.

Keywords: FoxO1; STAT1; apoptosis; diabetic kidney disease; tubulointerstitial fibrosis

Suggested Citation

Qin, Guijun and Huang, Fengjuan and Wang, Qingzhu and Guo, Feng and Zhao, Yanyan and Ji, Linlin and An, Tingting and Song, Yi and Liu, Yang and He, Yanyan, FoxO1-Mediated Inhibition of STAT1 Alleviates Tubulointerstitial Fibrosis and Tubule Apoptosis in Diabetic Kidney Disease (07/31/2019 09:04:21). Available at SSRN: https://ssrn.com/abstract=3429891 or http://dx.doi.org/10.2139/ssrn.3429891

Guijun Qin (Contact Author)

Zhengzhou University - Division of Endocrinology ( email )

Fengjuan Huang

Zhengzhou University - Division of Endocrinology

Zhengzhou, Henan 450052
China

Qingzhu Wang

Zhengzhou University - Division of Endocrinology

Zhengzhou, Henan 450052
China

Feng Guo

Zhengzhou University - Department of Endocrinology

Zhengzhou, Henan 450052
China

Yanyan Zhao

Zhengzhou University - Department of Endocrinology

Zhengzhou, Henan 450052
China

Linlin Ji

Zhengzhou University - First Affiliated Hospital

1 Eastern Jianshe Road
Henan, 450052
China

Tingting An

Zhengzhou University - First Affiliated Hospital

1 Eastern Jianshe Road
Henan, 450052
China

Yi Song

Zhengzhou University - First Affiliated Hospital

1 Eastern Jianshe Road
Henan, 450052
China

Yang Liu

Zhengzhou University - First Affiliated Hospital

1 Eastern Jianshe Road
Henan, 450052
China

Yanyan He

Zhengzhou University - First Affiliated Hospital

1 Eastern Jianshe Road
Henan, 450052
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
152
Downloads
11